Lidocaine/Sodium bicarbonate

利多卡因/碳酸氢钠

Report date: 2026/03/20 20:03:07

Base Information

Drug NameLidocaine/Sodium bicarbonate
Drug Alias Name碳酸氢钠/利多卡因Sodium bicarbonate and LidocaineLidocaine and sodium bicarbonate碳酸氢钠利多卡因利多卡因碳酸氢钠 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsBladder PainCystitis, Interstitial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes LidocaineSodium Bicarbonate
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPlethora Solutions Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPlethora Solutions Ltd
Inactive CompaniesN/A
Active IndicationsBladder PainCystitis, Interstitial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A